{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:10:04Z","timestamp":1783404604442,"version":"3.54.6"},"reference-count":143,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Currently, the symptomatic status and left ventricular ejection fraction (LVEF) play a crucial role in aortic stenosis (AS) assessment. However, the symptoms are often subjective, and LVEF is not a sensitive marker of left ventricle (LV) decompensation. Over the past years, the cardiac structure and function research on AS has increased due to advanced imaging modalities and potential therapies. New imaging parameters emerged as predictors of disease progression in AS. LV global longitudinal strain has proved useful for risk stratification in asymptomatic severe AS patients with preserved LVEF. The assessment of myocardial fibrosis by cardiac magnetic resonance is the most studied application and offers prognostic information on AS. Moreover, the usage of biomarkers in AS as objective measures of LV decompensation has recently gained more interest. The present review focuses on the transition from compensatory LV hypertrophy (H) to LV dysfunction and the biomarkers associated with myocardial wall stress, fibrosis, and myocyte death. Moreover, we discuss the potential impact of non-invasive imaging parameters for optimizing the timing of aortic valve replacement and provide insight into novel biomarkers for possible prognostic use in AS. However, data from randomized clinical trials are necessary to define their utility in daily practice.<\/jats:p>","DOI":"10.3390\/biom13111661","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:10:38Z","timestamp":1700212238000},"page":"1661","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel Biomarkers and Advanced Cardiac Imaging in Aortic Stenosis: Old and New"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2944-6527","authenticated-orcid":false,"given":"Anca","family":"Dr\u0103gan","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Anaesthesiology and Intensive Care, Emergency Institute for Cardiovascular Diseases \u201cProf Dr C C Iliescu\u201d, 258 Fundeni Road, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Doina","family":"Mateescu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Emergency Institute for Cardiovascular Diseases \u201cProf Dr C C Iliescu\u201d, 258 Fundeni Road, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"131155","DOI":"10.1016\/j.ijcard.2023.131155","article-title":"Growing prevalence of aortic stenosis\u2014Question of age or better recognition?","volume":"388","author":"Chatterjee","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Santangelo, G., Bursi, F., Faggiano, A., Moscardelli, S., Simeoli, P.S., Guazzi, M., Lorusso, R., Carugo, S., and Faggiano, P. (2023). The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062178"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2666-7568(22)00188-X","article-title":"Live longer and better without aortic valve stenosis","volume":"3","author":"Pibarot","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e001783","DOI":"10.1136\/openhrt-2021-001783","article-title":"Uncovering the treatable burden of severe aortic stenosis in the UK","volume":"9","author":"Strange","year":"2022","journal-title":"Open Heart"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/S2666-7568(22)00168-4","article-title":"Counting the cost of premature mortality with progressively worse aortic stenosis in Australia: A clinical cohort study","volume":"3","author":"Stewart","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"ESC\/EACTS Scientific Document Group. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/01.CIR.0000060533.79248.0C","article-title":"Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis","volume":"107","author":"Gerber","year":"2003","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCIMAGING.113.000636","article-title":"Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis","volume":"7","author":"Dahl","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2009.09.043","article-title":"Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis","volume":"105","author":"Lancellotti","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/hrt.2009.190942","article-title":"Risk stratification in asymptomatic moderate to severe aortic stenosis: The importance of the valvular, arterial and ventricular interplay","volume":"96","author":"Lancellotti","year":"2010","journal-title":"Heart"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-016-9589-9","article-title":"Left atrium: The last bulwark before overt heart failure","volume":"22","author":"Cameli","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse Myocardial Remodeling Following Valve Replacement in Patients with Aortic Stenosis","volume":"71","author":"Treibel","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: An invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14779072.2023.2186853","article-title":"Heart failure and excess mortality after aortic valve replacement in aortic stenosis","volume":"21","author":"Aziminia","year":"2023","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e023466","DOI":"10.1161\/JAHA.121.023466","article-title":"Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis","volume":"11","author":"Stein","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/hrt.2005.062422","article-title":"Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: A transthoracic Doppler and myocardial contrast echocardiography study","volume":"92","author":"Galiuto","year":"2006","journal-title":"Heart"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1152\/japplphysiol.00049.2008","article-title":"Impairment of coronary flow reserve in aortic stenosis","volume":"106","author":"Garcia","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/heartjnl-2017-311506","article-title":"The role and clinical implications of diastolic dysfunction in aortic stenosis","volume":"103","author":"Kampaktsis","year":"2017","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2020.10.034","article-title":"Aortic Stenosis and Diastolic Dysfunction","volume":"76","author":"Klein","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.shj.2022.100089","article-title":"Left Ventricular Systolic Dysfunction in Aortic Stenosis: Pathophysiology, Diagnosis, Management, and Future Directions","volume":"6","author":"Spilias","year":"2022","journal-title":"Struct. Heart"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/heartjnl-2022-320886","article-title":"Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis","volume":"108","author":"Stassen","year":"2022","journal-title":"Heart"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Fragogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCULATIONAHA.104.516963","article-title":"Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart","volume":"112","author":"Heymans","year":"2005","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0735-1097(01)01170-6","article-title":"Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease","volume":"37","author":"Fielitz","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E147","DOI":"10.1093\/eurheartj\/suab120","article-title":"Clinical impact of myocardial fibrosis in severe aortic stenosis","volume":"23","author":"Castrichini","year":"2021","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurheartj\/15.suppl_D.45","article-title":"Regulation of the structural remodelling of the myocardium: From hypertrophy to heart failure","volume":"15","author":"Brilla","year":"1994","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: Possible role during stress and remodeling","volume":"64","author":"Schellings","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/physrev.00008.2011","article-title":"Matricellular proteins in cardiac adaptation and disease","volume":"92","author":"Frangogiannis","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e003126","DOI":"10.1161\/JAHA.115.003126","article-title":"Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure","volume":"5","author":"Salvador","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","article-title":"Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis","volume":"43","author":"Tokuda","year":"2004","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"ehac544-2996","DOI":"10.1093\/eurheartj\/ehac544.2996","article-title":"Histology-verified myocardial fibrosis and quantification in severe AS patients: Correlation with non-invasive LV myocardial tissue assessment","volume":"43","author":"Maltes","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1136\/heartjnl-2011-300069","article-title":"Left atrial function: Pathophysiology, echocardiographic assessment, and clinical applications","volume":"97","author":"Rosca","year":"2011","journal-title":"Heart"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sygitowicz, G., Maciejak-Jastrz\u0119bska, A., and Sitkiewicz, D. (2021). A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194430"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Moln\u00e1r, A.\u00c1., S\u00e1nta, A., P\u00e1sztor, D.T., and Merkely, B. (2023). Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives. Cells, 12.","DOI":"10.3390\/cells12131796"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6312100","DOI":"10.1155\/2022\/6312100","article-title":"Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation","volume":"2022","author":"Zheng","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Frag\u00e3o-Marques, M., Miranda, I., Martins, D., Barroso, I., Mendes, C., Pereira-Neves, A., Falc\u00e3o-Pires, I., and Leite-Moreira, A. (2020). Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01754-0"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2011.02.059","article-title":"Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome","volume":"58","author":"Herrmann","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcmg.2018.11.005","article-title":"Distribution and Prognostic Significance of Left Ventricular Global Longitudinal Strain in Asymptomatic Significant Aortic Stenosis: An Individual Participant Data Meta-Analysis","volume":"12","author":"Magne","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.ijcard.2012.06.012","article-title":"Longitudinal left ventricular 2D strain is superior to ejection fraction in predicting myocardial recovery and symptomatic improvement after aortic valve implantation","volume":"167","author":"Kempny","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5603\/CJ.a2018.0066","article-title":"Immediate improvement of left ventricular mechanics following transcatheter aortic valve replacement","volume":"25","author":"Faletra","year":"2018","journal-title":"Cardiol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.amjcard.2010.06.029","article-title":"Impact of aortic valve stenosis on left atrial phasic function","volume":"106","author":"Magne","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.echo.2018.11.007","article-title":"Left Atrial Dysfunction as an Independent Correlate of Heart Failure Symptoms in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction","volume":"32","author":"Mateescu","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.echo.2017.07.001","article-title":"Atrial Function as an Independent Predictor of Postoperative Atrial Fibrillation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Stenosis","volume":"30","author":"Pernigo","year":"2017","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ejechocard\/jer006","article-title":"Left atrial function and remodelling in aortic stenosis","volume":"12","author":"Magne","year":"2011","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0002-9149(98)00452-4","article-title":"Increasing degrees of left ventricular filling impairment modulate left atrial function in humans","volume":"82","author":"Prioli","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/CIRCEP.111.964783","article-title":"Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload","volume":"4","author":"Kim","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ehjci\/jes102","article-title":"Diffuse myocardial fibrosis in severe aortic stenosis: An equilibrium contrast cardiovascular magnetic resonance study","volume":"13","author":"Flett","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e007451","DOI":"10.1161\/CIRCIMAGING.117.007451","article-title":"Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study","volume":"11","author":"Everett","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.117.032839","article-title":"Myocardial Scar and Mortality in Severe Aortic Stenosis","volume":"138","author":"Musa","year":"2018","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2019.02.018","article-title":"P et al. Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial","volume":"212","author":"Bing","year":"2019","journal-title":"Am. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcmg.2017.09.005","article-title":"Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients with Aortic Stenosis","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Nangia-Makker, P., Hogan, V., Balan, V., and Raz, A. (2022). Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.102622"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbamcr.2014.12.001","article-title":"Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression","volume":"1853","author":"Song","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1042\/CS20171389","article-title":"Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage","volume":"132","author":"Ibarrola","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","article-title":"Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis","volume":"186","author":"Frunza","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1042\/CS20170145","article-title":"A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis","volume":"131","author":"Arrieta","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/heartjnl-2015-308873","article-title":"Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis","volume":"102","author":"Arangalage","year":"2016","journal-title":"Heart"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bobrowska, B., Wieczorek-Surdacka, E., Kruszelnicka, O., Chyrchel, B., Surdacki, A., and Dudek, D. (2017). Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050947"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.11152\/mu-1456","article-title":"The value of global longitudinal strain and galectin-3 for predicting cardiovascular events in patients with severe aortic stenosis","volume":"20","author":"Bheecarry","year":"2018","journal-title":"Med. Ultrason"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"783707","DOI":"10.3389\/fcvm.2022.783707","article-title":"Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis","volume":"9","author":"Cheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/bmm.15.121","article-title":"Using the galectin-3 test to predict mortality in heart failure patients: A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2016","journal-title":"Biomark. Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Sherpa, M.D., Sonkawade, S.D., Jonnala, V., Pokharel, S., Khazaeli, M., Yatsynovich, Y., Kalot, M.A., Weil, B.R., Canty, J.M., and Sharma, U.C. (2023). Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death. Cells, 12.","DOI":"10.3390\/cells12091218"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Baran, J., Niewiara, \u0141., Podolec, J., Siedli\u0144ski, M., J\u00f3zefczuk, E., Bernacik, A., Badacz, R., Przew\u0142ocki, T., Pieni\u0105\u017cek, P., and \u017bmudka, K. (2022). Serum and Vascular Stiffness Biomarkers Associated with the Severity of Degenerative Aortic Valve Stenosis and Cardiovascular Outcomes. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9060193"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"White, M., Baral, R., Ryding, A., Tsampasian, V., Ravindrarajah, T., Garg, P., Koskinas, K.C., Clark, A., and Vassiliou, V.S. (2021). Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis. Med. Sci., 9.","DOI":"10.3390\/medsci9020029"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.hlc.2015.08.021","article-title":"The Relationship between Galectin-3 and Different Patterns of Ventricular Geometry Remodelling in Aortic Valve Stenosis","volume":"25","author":"Zhou","year":"2016","journal-title":"Heart Lung Circ."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Ramos, M., Quezada-Feijo\u00f3, M., Ayala, R., Manzano, A., G\u00f3mez-Pav\u00f3n, F.J., Jaramillo, J., Herrera, C., L\u00f3pez Vazquez de la Torre, M., and Toro, R. (2023). Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-up of Asymptomatic Elderly Patients with Severe Aortic Stenosis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082987"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e13186","DOI":"10.2196\/13186","article-title":"Aortic Stenosis Prognostication in Patients with Type 2 Diabetes: Protocol for Testing and Validation of a Biomarker-Derived Scoring System","volume":"8","author":"Giritharan","year":"2019","journal-title":"JMIR Res. Protoc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cca.2019.05.023","article-title":"ST2 and the ST2\/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans","volume":"495","author":"Pusceddu","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1042\/CS20190475","article-title":"Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: An in vitro and in vivo study in aortic stenosis","volume":"133","author":"Matilla","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lancellotti, P., Dulgheru, R., Magne, J., Henri, C., Servais, L., Bouznad, N., Ancion, A., Martinez, C., Davin, L., and Le Goff, C. (2015). Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138940"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.recesp.2022.12.003","article-title":"Soluble ST2 levels are related to replacement myocardial fibrosis in severe aortic stenosis","volume":"76","author":"Arrieta","year":"2023","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Boxhammer, E., Mirna, M., B\u00e4z, L., Bacher, N., Topf, A., Sipos, B., Franz, M., Kretzschmar, D., Hoppe, U.C., and Lauten, A. (2022). Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?. Life, 12.","DOI":"10.3390\/life12030389"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s10554-017-1203-2","article-title":"The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: A translational imaging approach","volume":"33","author":"Fabiani","year":"2017","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_82","first-page":"93","article-title":"Diagnostic utility of biomarkers of left ventricular stress in patients with aortic stenosis and preserved left ventricular ejection fraction","volume":"14","author":"Sobczak","year":"2017","journal-title":"Kardiochir. Torakochirurgia Pol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.7754\/Clin.Lab.2022.221036","article-title":"Diverging Concentrations of Soluble Suppression of Tumorigenicity (sST2) Analyzed by two Different Assays\u2014A Limitation for its use in Clinical Practice?","volume":"69","author":"Mirna","year":"2023","journal-title":"Clin. Lab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/heartjnl-2015-307742","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement","volume":"101","author":"Lindman","year":"2015","journal-title":"Heart"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, J., Liew, O.W., Richards, A.M., and Chen, Y.T. (2016). Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050749"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.bbadis.2015.04.006","article-title":"p-SMAD2\/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling","volume":"1852","author":"Nistal","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/cts.13303","article-title":"A systematic review of micro-RNAs in aortic stenosis and cardiac fibrosis","volume":"15","author":"Adewuyi","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.117.10094","article-title":"MicroRNA-221\/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure","volume":"71","author":"Verjans","year":"2018","journal-title":"Hypertension"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Garc\u00eda, R., Salido-Medina, A.B., Gil, A., Merino, D., G\u00f3mez, J., Villar, A.V., Gonz\u00e1lez-V\u00edlchez, F., Hurl\u00e9, M.A., and Nistal, J.F. (2020). Sex-Specific Regulation of miR-29b in the Myocardium Under Pressure Overload is Associated with Differential Molecular, Structural and Functional Remodeling Patterns in Mice and Patients with Aortic Stenosis. Cells, 9.","DOI":"10.3390\/cells9040833"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2015.05.185","article-title":"Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy","volume":"196","author":"Derda","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"R\u00f8sj\u00f8, H., Dahl, M.B., Bye, A., Andreassen, J., J\u00f8rgensen, M., Wisl\u00f8ff, U., Christensen, G., Edvardsen, T., and Omland, T. (2014). Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091812"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e000211","DOI":"10.1161\/JAHA.113.000211","article-title":"Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis","volume":"2","author":"Villar","year":"2013","journal-title":"J. Am. Heart. Assoc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.ijcard.2012.07.021","article-title":"Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients","volume":"167","author":"Villar","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12967-016-1011-9","article-title":"Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: A pilot study","volume":"14","author":"Fabiani","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2211-4122.192132","article-title":"Review in Translational Cardiology: MicroRNAs and Myocardial Fibrosis in Aortic Valve Stenosis, a Deep Insight on Left Ventricular Remodeling","volume":"26","author":"Iacopo","year":"2016","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Rochette, L., Dogon, G., Zeller, M., Cottin, Y., and Vergely, C. (2021). GDF15 and Cardiac Cells: Current Concepts and New Insights. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168889"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Tretjakovs, P., Lurins, J., Svirskis, S., Gersone, G., Lurina, D., Rozenberga, U., Blumfelds, L., Bahs, G., Lejnieks, A., and Mackevics, V. (2021). Thioredoxin-1 and Correlations of the Plasma Cytokines Regarding Aortic Valve Stenosis Severity. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081041"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hofmanis, J., Tretjakovs, P., Svirskis, S., Gersone, G., Hofmane, D., Rozenberga, U., Blumfelds, L., Bahs, G., Lejnieks, A., and Mackevics, V. (2021). Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study. Medicina, 57.","DOI":"10.3390\/medicina57010078"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2022.09.029","article-title":"Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients with Aortic Stenosis and Preserved Left Ventricular Ejection Fraction","volume":"186","author":"Basmadjian","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Fabiani, I., Santoni, T., Angelillis, M., Petricciuolo, S., Colli, A., Pellegrini, G., Mazzei, D., Pugliese, N.R., Petronio, A.S., and De Caterina, R. (2020). Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092998"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Gumauskien\u0117, B., Krivickien\u0117, A., Jonkaitien\u0117, R., Va\u0161kelyt\u0117, J.J., Siudikas, A., and Ereminien\u0117, E. (2018). Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis. Medicina, 54.","DOI":"10.3390\/medicina54040063"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Frag\u00e3o-Marques, M., Barroso, I., Farinha, R., Miranda, I.M., Martins, D., Mancio, J., Rocha-Neves, J., Guimar\u00e3es, J.T., Leite-Moreira, A., and Falc\u00e3o-Pires, I. (2021). Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11081422"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhang, T., Xue, Q., Zhu, R., and Jiang, Y. (Clin. Cardiol., 2022). Diagnostic Value of PICP and PIIINP in Myocardial Fibrosis: A Systematic Review and Meta-analysis, Clin. Cardiol., Online ahead of print.","DOI":"10.1002\/clc.23901"},{"key":"ref_104","first-page":"166","article-title":"Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis","volume":"22","author":"Kupari","year":"2013","journal-title":"J. Heart Valve Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2010.10.036","article-title":"Plasma amino-terminal propeptide of procollagen type III is associated with subclinical left ventricular systolic dysfunction in aortic stenosis","volume":"156","author":"Du","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diii.2020.07.005","article-title":"Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference","volume":"102","author":"Foussier","year":"2021","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12968-022-00874-0","article-title":"Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: A prospective cardiovascular magnetic resonance study","volume":"24","author":"Lange","year":"2022","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00109-004-0606-4","article-title":"Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients vwith aortic stenosis","volume":"82","author":"Fielitz","year":"2004","journal-title":"J. Mol. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1440-1681.12206","article-title":"Association of inflammation, myocardial fibrosis and cardiac remodelling in patients with mild aortic stenosis as assessed by biomarkers and echocardiography","volume":"41","author":"Park","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_110","first-page":"2433","article-title":"Impact of several proinflammatory and cell degradation factors in patients with aortic valve stenosis","volume":"17","author":"Lurins","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2004.07.023","article-title":"Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression","volume":"44","author":"Polyakova","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"B\u00e4z, L., Dannberg, G., Gr\u00fcn, K., Westphal, J., M\u00f6bius-Winkler, S., Jung, C., Pfeil, A., Schulze, P.C., and Franz, M. (2020). Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114174"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ejheart.2008.09.010","article-title":"Alterations in circulating activin A, GDF-15, TGF-beta3 and MMP-2, -3, and -9 during one year of left ventricular reverse remodelling in patients operated for severe aortic stenosis","volume":"10","author":"Neverdal","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/13813451003652997","article-title":"MMP-2\/TIMP-2\/TIMP-4 versus MMP-9\/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure","volume":"116","author":"Givvimani","year":"2010","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/CS20040098","article-title":"Invasive measurements of pulse wave velocity correlate with the degree of aortic valve calcification and severity associated with matrix metalloproteinases in elderly patients with aortic valve stenosis","volume":"107","author":"Liu","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e925260","DOI":"10.12659\/MSM.925260","article-title":"Correlation Between Plasma Matrix Metalloproteinase-28 Levels and Severity of Calcific Aortic Valve Stenosis","volume":"26","author":"Zhou","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Omran, F., Kyrou, I., Osman, F., Lim, V.G., Randeva, H.S., and Chatha, K. (2022). Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105680"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Cao, Z., Jia, Y., and Zhu, B. (2019). BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081820"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yjmcc.2019.03.011","article-title":"Molecular and clinical implications of natriuretic peptides in aortic valve stenosis","volume":"129","author":"Gallo","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2020.02.031","article-title":"CHINA-DVD Collaborators. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease","volume":"75","author":"Zhang","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/heartjnl-2019-315672","article-title":"CURRENT AS registry Investigators. Contemporary issues in severe aortic stenosis: Review of current and future strategies from the Contemporary Outcomes after Surgery and Medical Treatment in Patients with Severe Aortic Stenosis registry","volume":"106","author":"Taniguchi","year":"2020","journal-title":"Heart"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Klaar","year":"2004","journal-title":"Circulation"},{"key":"ref_123","first-page":"384","article-title":"CURRENT AS Registry Investigators. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis","volume":"105","author":"Nakatsuma","year":"2019","journal-title":"Heart"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2021.03.017","article-title":"Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis\u2014Results from a subanalysis of the PROGRESSA study","volume":"332","author":"Bernard","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e002361","DOI":"10.1136\/openhrt-2023-002361","article-title":"Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease","volume":"10","author":"Bernard","year":"2023","journal-title":"Open Heart"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/hrt.2005.085506","article-title":"Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis","volume":"92","author":"Weber","year":"2006","journal-title":"Heart"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.amjcard.2020.02.004","article-title":"Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients with Moderate Aortic Stenosis","volume":"125","author":"Ito","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.amjcard.2019.09.014","article-title":"Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis","volume":"124","author":"Barbieri","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Auensen, A., Hussain, A.I., Falk, R.S., Walle-Hansen, M.M., Bye, J., Pettersen, K.I., Aukrust, P., Ueland, T., and Gullestad, L.L. (2017). Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179304"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"101875","DOI":"10.1016\/j.eclinm.2023.101875","article-title":"Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: A post-hoc substudy of the SEAS trial","volume":"58","author":"Hadziselimovic","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/1354750X.2019.1567818","article-title":"High-sensitivity troponin T in asymptomatic severe aortic stenosis","volume":"24","author":"Cediel","year":"2019","journal-title":"Biomarkers"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e001325","DOI":"10.1136\/openhrt-2020-001325","article-title":"Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: A population-based nested case-referent study","volume":"7","author":"Holmgren","year":"2020","journal-title":"Open Heart"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Dr\u0103gan, A., and Sinescu, I. (2023). The Role of the Cardiac Biomarkers in the Renal Cell Carcinoma Multidisciplinary Management. Diagnostics, 13.","DOI":"10.3390\/diagnostics13111912"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e026529","DOI":"10.1161\/JAHA.122.026529","article-title":"Global Longitudinal Strain and Biomarkers of Cardiac Damage and Stress as Predictors of Outcomes After Transcatheter Aortic Valve Implantation","volume":"11","author":"Perry","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Frag\u00e3o-Marques, M., Vitorino, R., Barroso, I., Falc\u00e3o-Pires, I., Leite-Moreira, A., and Trindade, F. (2022). Pericardial Fluid Annexin A1 Is a Marker of Atrial Fibrillation in Aortic Stenosis: A Proteomics Analysis. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020264"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hu, P., Chen, H., Wang, L.H., Jiang, J.B., Li, J.M., Tang, M.Y., Guo, Y.C., Zhu, Q.F., Pu, Z.X., and Lin, X.P. (2022). Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02615-8"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/heartjnl-2021-320707","article-title":"Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis","volume":"108","author":"Tan","year":"2022","journal-title":"Heart"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Abdelaziz Mohamed, I., Gadeau, A.P., Hasan, A., Abdulrahman, N., and Mraiche, F. (2019). Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis. Cells, 8.","DOI":"10.3390\/cells8121558"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e000633","DOI":"10.1136\/openhrt-2017-000633","article-title":"Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)","volume":"4","author":"Lutz","year":"2017","journal-title":"Open Heart"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/bmm-2019-0410","article-title":"Osteopontin as novel biomarker for reversibility of pressure overload induced left ventricular hypertrophy","volume":"14","author":"Weber","year":"2020","journal-title":"Biomark. Med."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Villar, A.V., Cobo, M., Llano, M., Montalvo, C., Gonz\u00e1lez-V\u00edlchez, F., Mart\u00edn-Dur\u00e1n, R., Hurl\u00e9, M.A., and Nistal, J.F. (2009). Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008476"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc. Imaging."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1753944719826420","DOI":"10.1177\/1753944719826420","article-title":"Serum copeptin might improve risk stratification and management of aortic valve stenosis: A review of pathophysiological insights and practical implications","volume":"13","author":"Yalta","year":"2019","journal-title":"Ther. Adv. Cardiovasc. Dis."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1661\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:24:42Z","timestamp":1760131482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":143,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["biom13111661"],"URL":"https:\/\/doi.org\/10.3390\/biom13111661","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}